Back to the main directory
EarningsReview / Equity
- Altri - 4Q24 results beat expectations, reiterating Buy by JB Capital Markets
- CTT - Beat on strong E&P and FS recovery; reiterating Buy by JB Capital Markets
- Ramada - Slight EBITDA miss, but in-line FCF, we remain Neutral by JB Capital Markets
- Reducing complexity - PSM acquiring minority stake in NuCom Group by BNP Paribas Exane
- CEO/CFO Roadshow feedback by BNP Paribas Exane
- Unidata S.p.A - FY24: résultats en ligne, les JV doivent mûrir et les perspectives positives ont été confirmées by MidCap Partners
- INVEST SECURITIES - NEMETSCHEK : Valorisation à la hauteur de la croissance organique - NEUTRE vs VENTE, OC 108€ vs 94€ by Invest Securities
- European CSD Data (Nielsen, Feb’25): Industry sales in slight decline by BNP Paribas Exane
- Unidata S.p.A - FY24: results in line, JVs need to mature and positive outlook confirmed by MidCap Partners
- Fermentalg SA - The Huvepharma effect is becoming visible by MidCap Partners
- Fortum - Dividend hype overdone by Danske Bank Equity Research
- Going global and vertical by BNP Paribas Exane
- Powering through the near-term trough by BNP Paribas Exane
- Gaining momentum and market share by BNP Paribas Exane
- H1 trading update: adj. EBITDA guide ‘ahead’ by BNP Paribas Exane
- Results Flash - Q4 EBITDA in-line with pre-release, strong FCF, cautious outlook by BNP Paribas Exane
- Substation fire near Heathrow airport by BNP Paribas Exane
- Mid-quarter guide - In-line Q1 by BNP Paribas Exane
- Vetoquinol - We feared the worst, but they delivered the best by MidCap Partners
- Mid-quarter guide - Large Q1 EPS miss by BNP Paribas Exane
- Underlying trends continued in Q4 by BNP Paribas Exane
- The Weekly Checkout by BNP Paribas Exane
- Most Read Research - Week 14-20 March 2025 by BNP Paribas Exane
- Itaú BBA on Homebuilders: 4Q24 Operating Pack – MELK & HBOR by Itau
- China Power International (2380 HK) by HSBC
- Conference Guide by BNP Paribas Exane
- Hapag-Lloyd AG (HLAG GY) by HSBC
- A third consecutive cut to guidance by BNP Paribas Exane
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- Fermentalg SA - L’effet Huvepharma commence à être visible by MidCap Partners
- Wallix - Promesse tenue ! by MidCap Partners
- Cloudy horizons by BNP Paribas Exane
- European Spirits Data (Nielsen, Feb’25): Softer industry weighs on Pernod and Campari by BNP Paribas Exane
- Wallix - Promise kept! by MidCap Partners
- European Beer Data (Nielsen, Feb’25): Softer industry vols by BNP Paribas Exane
- Sizeable acquisition announced by BNP Paribas Exane
- The contemporary, and future, winner by BNP Paribas Exane
- Asia’s batteries: Shining bright, unlike solar by BNP Paribas Exane
- Well-positioned to capture ex-China growth by BNP Paribas Exane
- European Food/HPC Data (Nielsen, Feb'25): weaker for most, Nestle - a positive stand-out by BNP Paribas Exane
- BOL by BNP Paribas Exane
- Pulp: China prices flat as Shanghai pulp week comes to a close by BNP Paribas Exane
- EURO. BOX & PACKAGING: Notable weakness in February FMCG vols driven by softening across all categories by BNP Paribas Exane
- Nuggets from the annual and compensation reports by BNP Paribas Exane
- Downside risk to consensus Renewable Fuel margins by BNP Paribas Exane
- Feedback from pre-close call by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Itaú BBA on Cemig: In-Line Results and Dividend Announcement by Itau
- Itaú BBA on Wiz: Mixed 4Q24 by Itau
- Itaú BBA Credit Research on Movida: Quick Take on 4Q24 Results by Itau